456 related articles for article (PubMed ID: 12739070)
21. Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.
Vermeersch H; Loose D; Ham H; Otte A; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1689-700. PubMed ID: 14574516
[TBL] [Abstract][Full Text] [Related]
22. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
23. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Al-Bulushi NK; Abouzied ME
Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
[TBL] [Abstract][Full Text] [Related]
25. FDG PET/MR for lymph node staging in head and neck cancer.
Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J
Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792
[TBL] [Abstract][Full Text] [Related]
26. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
27. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
28. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients.
Paulus P; Sambon A; Vivegnis D; Hustinx R; Moreau P; Collignon J; Deneufbourg JM; Rigo P
Laryngoscope; 1998 Oct; 108(10):1578-83. PubMed ID: 9778305
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
[TBL] [Abstract][Full Text] [Related]
30. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
[TBL] [Abstract][Full Text] [Related]
31. [F-18 FDG PET for detection of occult primary tumor in patients with lymphatic metastases of the neck region].
Bohuslavizki KH; Klutmann S; Sonnemann U; Thoms J; Kröger S; Werner JA; Mester J; Clausen M
Laryngorhinootologie; 1999 Aug; 78(8):445-9. PubMed ID: 10488465
[TBL] [Abstract][Full Text] [Related]
32. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary.
Paul SA; Stoeckli SJ; von Schulthess GK; Goerres GW
Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):189-95. PubMed ID: 17177026
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
34. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Fuster D; Chiang S; Johnson G; Schuchter LM; Zhuang H; Alavi A
J Nucl Med; 2004 Aug; 45(8):1323-7. PubMed ID: 15299056
[TBL] [Abstract][Full Text] [Related]
35. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
36. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
[TBL] [Abstract][Full Text] [Related]
37. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck.
Goerres GW; Haenggeli CA; Allaoua M; Albrecht SR; Dulguerov P; Becker M; Allal AS; Lehmann W; Slosman DO
Nuklearmedizin; 2000 Dec; 39(8):246-50. PubMed ID: 11189902
[TBL] [Abstract][Full Text] [Related]
38. Assessment of clinical utility of 18F-FDG PET in patients with head and neck cancer: a probability analysis.
Goerres GW; Mosna-Firlejczyk K; Steurer J; von Schulthess GK; Bachmann LM
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):562-71. PubMed ID: 12589477
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of
Ruhlmann V; Poeppel TD; Veit J; Nagarajah J; Umutlu L; Hoffmann TK; Bockisch A; Herrmann K; Sauerwein W
BMC Cancer; 2017 Dec; 17(1):887. PubMed ID: 29273015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
